1,086 results on '"Van Den Berg, Maarten P."'
Search Results
2. Diagnostic yield and therapeutic implications of 25 years of specialized pediatric Marfan clinic
3. International shipping in a world below 2 °C
4. Spread in climate policy scenarios unravelled
5. A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients
6. Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers
7. ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy
8. SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades
9. Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy
10. Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
11. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy
12. Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy
13. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy
14. Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms
15. Introduction to Hereditary Cardiomyopathies
16. TAB2 deletions and variants cause a highly recognisable syndrome with mitral valve disease, cardiomyopathy, short stature and hypermobility
17. ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy
18. Cardiac [99mTc]Tc‑hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis:an early follow‑up marker?
19. Abstract 12547: Obesity as Risk Factor for Malignant Ventricular Arrhythmias in Phospholamban Cardiomyopathy
20. Abstract 11933: Cardiac and Fibrosis-Related Biomarker Levels Do Not Predict Disease Development in Presymptomatic Phospholamban Cardiomyopathy
21. Co-benefits of black carbon mitigation for climate and air quality
22. The natural progression of a fistulizing gallstone resulting in massive gastrointestinal hemorrhage and Bouveret syndrome, a rare case
23. The costs of achieving climate targets and the sources of uncertainty
24. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
25. Genome-wide methylation patterns in Marfan syndrome
26. Non-invasive method to detect high respiratory effort and transpulmonary driving pressures in COVID-19 patients during mechanical ventilation
27. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy
28. Multicentre experience with valve-sparing aortic root replacement by means of combined remodelling and external aortic ring annuloplasty in patients with Marfan syndrome
29. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete’s Heart
30. Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy
31. Frequency of and Prognostic Significance of Cardiac Involvement at Presentation in Hereditary Transthyretin-Derived Amyloidosis and the Value of N-Terminal Pro-B-Type Natriuretic Peptide
32. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration
33. Introduction Hereditary Cardiomyopathies
34. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy
35. Publisher Correction: Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
36. Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
37. The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
38. Advanced respiratory monitoring in COVID-19 patients: use less PEEP!
39. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
40. Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
41. Toward an effective exome-based genetic testing strategy in pediatric dilated cardiomyopathy
42. Alternative pathways to the 1.5 °C target reduce the need for negative emission technologies
43. A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
44. A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
45. Variant Location Is a Novel Risk Factor for Individuals with Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
46. A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
47. Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers
48. Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy
49. Variant Location Is a Novel Risk Factor for Individuals with Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant
50. A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.